(Partial) Loss of BAF250a (ARID1A) in rectovaginal deep-infiltrating endometriosis, endometriomas and involved pelvic sentinel lymph nodes (Q38913558)

7 September 2017

(Partial) Loss of BAF250a (ARID1A) in rectovaginal deep-infiltrating endometriosis, endometriomas and involved pelvic sentinel lymph nodes (English)

1 reference

7 September 2017

0 references

1 reference

G M Borrelli

1

1 reference

7 September 2017

M S Abrão

2

1 reference

7 September 2017

E T Taube

3

1 reference

7 September 2017

S Darb-Esfahani

4

1 reference

7 September 2017

C Köhler

5

1 reference

7 September 2017

V Chiantera

6

1 reference

7 September 2017

S Mechsner

7

1 reference

7 September 2017

31 January 2016

1 reference

Molecular Human Reproduction

7 September 2017

1 reference

7 September 2017

22

1 reference

7 September 2017

329-337

1 reference

7 September 2017

5

1 reference

Extragenital endometrial stromal sarcoma arising in endometriosis

7 September 2017

1 reference

https://api.crossref.org/works/10.1093%2FMOLEHR%2FGAW009

Loss of ARID1A expression is an early molecular event in tumor progression from ovarian endometriotic cyst to clear cell and endometrioid carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FMOLEHR%2FGAW009

Treg functional stability and its responsiveness to the microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FMOLEHR%2FGAW009

Immunohistochemical Investigation of Metastasis-Related Chemokines in Deep-Infiltrating Endometriosis and Compromised Pelvic Sentinel Lymph Nodes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FMOLEHR%2FGAW009

Coexistent ARID1A-PIK3CA mutations promote ovarian clear-cell tumorigenesis through pro-tumorigenic inflammatory cytokine signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FMOLEHR%2FGAW009

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FMOLEHR%2FGAW009

Mutation and loss of expression of ARID1A in uterine low-grade endometrioid carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FMOLEHR%2FGAW009

Roles of deletion of Arid1a, a tumor suppressor, in mouse ovarian tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FMOLEHR%2FGAW009

Integrated genomic characterization of endometrial carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FMOLEHR%2FGAW009

Risk and prognosis of ovarian cancer in women with endometriosis: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FMOLEHR%2FGAW009

Fetal programming theory: implication for the understanding of endometriosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FMOLEHR%2FGAW009

The Risks for Ovarian, Endometrial, Breast, Colorectal, and Other Cancers in Women With Newly Diagnosed Endometriosis or Adenomyosis: A Population-Based Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FMOLEHR%2FGAW009

Interplay between Misplaced Müllerian-Derived Stem Cells and Peritoneal Immune Dysregulation in the Pathogenesis of Endometriosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FMOLEHR%2FGAW009

Whole-exome sequencing combined with functional genomics reveals novel candidate driver cancer genes in endometrial cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FMOLEHR%2FGAW009

Shared genetics underlying epidemiological association between endometriosis and ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FMOLEHR%2FGAW009

Clinicopathological significance of loss of ARID1A immunoreactivity in ovarian clear cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FMOLEHR%2FGAW009

Ovarian cancer in endometriosis: molecular biology, pathology, and clinical management

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FMOLEHR%2FGAW009

Loss of ARID1A expression correlates with stages of tumor progression in uterine endometrioid carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FMOLEHR%2FGAW009

Estrogen and progestogen receptor positive endometriotic lesions and disseminated cells in pelvic sentinel lymph nodes of patients with deep infiltrating rectovaginal endometriosis: a pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FMOLEHR%2FGAW009

Immunohistochemical evaluation of endometriotic lesions and disseminated endometriosis-like cells in incidental lymph nodes of patients with endometriosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FMOLEHR%2FGAW009

Endometriosis as a prognostic factor for cancer survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FMOLEHR%2FGAW009

Malignant transformation of endometriosis and its clinical significance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FMOLEHR%2FGAW009

Regression of latent endometrial precancers by progestin infiltrated intrauterine device

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FMOLEHR%2FGAW009

Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case-control studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FMOLEHR%2FGAW009

Behavior of tumor necrosis factor-α and tumor necrosis factor receptor 1/tumor necrosis factor receptor 2 system in mononuclear cells recovered from peritoneal fluid of women with endometriosis at different stages

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FMOLEHR%2FGAW009

Loss of ARID1A/BAF250a-expression in endometriosis: a biomarker for risk of carcinogenic transformation?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FMOLEHR%2FGAW009

Loss of ARID1A expression sensitizes cancer cells to PI3K- and AKT-inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FMOLEHR%2FGAW009

Once a Treg, always a Treg?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FMOLEHR%2FGAW009

Cellular, histologic, and molecular changes associated with endometriosis and ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FMOLEHR%2FGAW009

Correlation between dioxin and endometriosis: an epigenetic route to unravel the pathogenesis of the disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FMOLEHR%2FGAW009

Association between endometriosis and cancer: a comprehensive review and a critical analysis of clinical and epidemiological evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FMOLEHR%2FGAW009

Complement pathway is frequently altered in endometriosis and endometriosis-associated ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FMOLEHR%2FGAW009

Association of patterns of class I histone deacetylase expression with patient prognosis in gastric cancer: a retrospective analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FMOLEHR%2FGAW009

ARID1A mutations in endometriosis-associated ovarian carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FMOLEHR%2FGAW009

Loss of ARID1A protein expression occurs as an early event in ovarian clear-cell carcinoma development and frequently coexists with PIK3CA mutations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FMOLEHR%2FGAW009

Comparative study of ovarian clear cell carcinoma with and without endometriosis in People's Republic of China

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FMOLEHR%2FGAW009

A Coefficient of Agreement for Nominal Scales

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FMOLEHR%2FGAW009

21 January 2018

Identifiers

DOI

10.1093/MOLEHR/GAW009

1 reference

7 September 2017

1 reference